CHGCY
Price:
$23.78
Market Cap:
$11.93T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutic...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
PNK
Ticker
CHGCY
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 21.67%. This represents a change of 301.60% compared to the average of 5.40% of the last 4 quarters.
The mean historical ROE of Chugai Pharmaceutical Co., Ltd. over the last ten years is 16.15%. The current 21.67% ROE has changed 34.13% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's ROE was at its highest in in the March 2022 quarter at 10.62%. The ROE was at its lowest in in the December 2016 quarter at 1.63%.
Average
16.15%
Median
15.34%
Minimum
8.30%
Maximum
26.29%
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.78%
Maximum Annual ROE = 26.29%
Minimum Annual Increase = -23.83%
Minimum Annual ROE = 8.30%
Year | ROE | Change |
---|---|---|
2023 | 20.02% | -23.83% |
2022 | 26.29% | 3.07% |
2021 | 25.50% | 16.40% |
2020 | 21.91% | 18.76% |
2019 | 18.45% | 50.78% |
2018 | 12.24% | 16.44% |
2017 | 10.51% | 26.58% |
2016 | 8.30% | -14.99% |
2015 | 9.77% | 14.20% |
2014 | 8.55% | -3.93% |
The current ROE of Chugai Pharmaceutical Co., Ltd. (CHGCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
23.94%
5-year avg
22.43%
10-year avg
16.15%
Chugai Pharmaceutical Co., Ltd.’s ROE is less than Scilex Holding Company (64.26%), less than Merck & Co., Inc. (29.85%), less than Johnson & Johnson (20.94%), less than Pfizer Inc. (4.66%), less than Astellas Pharma Inc. (1.08%), greater than Bristol-Myers Squibb Company PFD CONV 2 (-36.26%), less than Otsuka Holdings Co., Ltd. (5.07%), less than Novartis AG (0%), less than AstraZeneca PLC (41.08%), less than GSK plc (16.80%), less than Roche Holding AG (18.08%), less than Bristol-Myers Squibb Company (54.68%), greater than Horizon Therapeutics Public Limited Company (-36.26%), less than Gilead Sciences, Inc. (5.86%), less than Sanofi (5.21%), less than null (10.71%),
Company | ROE | Market cap |
---|---|---|
64.26% | $185.04M | |
29.85% | $258.22B | |
20.94% | $380.98B | |
4.66% | $157.31B | |
1.08% | $19.92B | |
-36.26% | $113.09B | |
5.07% | $33.51B | |
0% | $216.23B | |
41.08% | $221.47B | |
16.80% | $75.40B | |
18.08% | $257.13B | |
54.68% | $112.46B | |
-36.26% | $0 | |
5.86% | $111.85B | |
5.21% | $132.76B | |
10.71% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chugai Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the highest ROE for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 3-year average ROE for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 5-year average ROE for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
How does the current ROE for Chugai Pharmaceutical Co., Ltd. (CHGCY) compare to its historical average?